Hyperglycaemia, instead of hyperinsulinaemia and hyperlipidaemia, can significantly induce the expression of SARS‐CoV‐2 entry factors in the liver, but not in the lung and pancreas, which is attenuated by the inhibition of mechanistic target of rapamycin kinase (mTOR). This evidence concerns the gene MTOR and hyperlipidemia.